Haug Partners LLP announced the appointment of Dr. Sandra Kuzmich ’01 to take over as Managing Partner of the firm.
Dr. Kuzmich joined Haug Partners in 1999 as a scientific advisor and became a partner in 2006. Since becoming a partner, she has served in multiple leadership positions in the Firm. Dr. Kuzmich served as Head of the Associates’ Committee, and was elected to the Firm’s Executive Committee and Compensation Committee. Until her election to Managing Partner, she has served as co-chair of Haug Partner’s Life Science practice.
Dr. Kuzmich received her undergraduate degree in chemistry from Douglass College of Rutgers University, Phi Beta Kappa, and earned her Ph.D. in pharmacology from Yale University. Upon earning her doctorate degree, she became a post-doctoral research associate with the Fox Chase Cancer Center. Dr. Kuzmich also spent several years in the pharmaceutical industry, managing departments in the United States in the areas of drug metabolism and pharmacokinetics and collaborating with Asian and European counterparts to coordinate worldwide regulatory submissions.
Dr. Kuzmich earned her J.D. in 2001 from Fordham University School of Law. Her practice focuses on patent litigation and strategic intellectual property counseling in the areas of pharmaceuticals, chemicals, and biotechnology. Her clients have included The Medicines Company, BioCryst Pharmaceuticals, Inc., Supernus, Sanofi, and Takeda.
Dr. Kuzmich is registered to practice before the U.S. Patent and Trademark Office and has been admitted to practice before the bars of New York, Connecticut, the Southern District of New York, the Eastern District of New York, and the U.S. Court of Appeals for the Federal Circuit. Dr. Kuzmich is a member of the New York Bar Association, the Connecticut Bar Association, and also the Federal Circuit Bar Association, where she currently serves on the Association’s Board of Directors.